Apply to trial NCT07285070

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Drug trial

Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

The primary objective of the study is to investigate the safety and tolerability of NOV05 eye drops at two concentrations QID in patients with active non-infectious anterior uveitis.

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We forward your profile to the study team

    They see only the answers needed to decide if you can be screened.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email so you can come back later, and the study team uses it to reach you.

By clicking Start, you agree to our terms of service.